LSA
SRPT icon

L & S Advisors’s Sarepta Therapeutics SRPT Stock Holding History

L & S Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,594
Closed -$1.76M – 367
2024
Q1 		$1.76M Sell
13,594
-798
-6% -$97.8K 0.2% 134
2023
Q4 		$1.39M Buy
14,392
+98
+0.7% +$9.4K 0.17% 135
2023
Q3 		$1.73M Buy
14,294
+3,880
+37% +$439K 0.25% 103
2023
Q2 		$1.19M Buy
10,414
+3,099
+42% +$400K 0.16% 135
2023
Q1 		$1.01M Sell
7,315
-2,829
-28% -$367K 0.14% 150
2022
Q4 		$1.31M Sell
10,144
-1,363
-12% -$158K 0.24% 101
2022
Q3 		$1.27M Buy
+11,507
New +$1.16M 0.22% 102
2021
Q1 		– Sell
-17,751
Closed -$3.03M – 391
2020
Q4 		$3.03M Buy
17,751
+7,995
+82% +$1.18M 0.35% 93
2020
Q3 		$1.37M Sell
9,756
-1,770
-15% -$269K 0.19% 158
2020
Q2 		$1.85M Sell
11,526
-784
-6% -$107K 0.28% 97
2020
Q1 		$1.2M Sell
12,310
-1,493
-11% -$171K 0.23% 103
2019
Q4 		$1.78M Sell
13,803
-105
-0.8% -$10.6K 0.23% 101
2019
Q3 		$1.05M Buy
13,908
+1,125
+9% +$133K 0.15% 170
2019
Q2 		$1.94M Sell
12,783
-610
-5% -$74.1K 0.26% 108
2019
Q1 		$1.6M Buy
13,393
+455
+4% +$58.5K 0.21% 110
2018
Q4 		$1.41M Buy
12,938
+825
+7% +$103K 0.27% 75
2018
Q3 		$1.96M Buy
12,113
+398
+3% +$54.4K 0.25% 93
2018
Q2 		$1.55M Sell
11,715
-98
-0.8% -$9.24K 0.26% 97
2018
Q1 		$875K Buy
11,813
+3,278
+38% +$219K 0.17% 133
2017
Q4 		$475K Buy
+8,535
New +$452K 0.07% 185

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

L & S Advisors's SRPT Position: Q2 2024 in Review

L & S Advisors sold out of Sarepta Therapeutics (SRPT) in Q2 2024, closing a stake of 13,594 shares — an estimated $1.76M sold.

L & S Advisors first reported a position in SRPT in Q4 2017 and held it in 20 quarters. The position peaked at $3.03M in Q4 2020. 483 funds tracked by Wall St. Rank hold SRPT as of Q2 2024.

  • L & S Advisors reported no remaining Sarepta Therapeutics position as of Q2 2024 after selling out during the quarter.
  • L & S Advisors sold 13,594 Sarepta Therapeutics shares in Q2 2024, an estimated $1.76M.
  • L & S Advisors first reported a position in Sarepta Therapeutics in Q4 2017 and held it in 20 quarters.
  • L & S Advisors's Sarepta Therapeutics position peaked at $3.03M in Q4 2020.
  • 483 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2024.

Based on L & S Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.